T24 [T-24] (人膀胱移行细胞癌细胞) (STR鉴定正确)

参考文献

• BCAT2 Shapes a Noninflamed Tumor Microenvironment and Induces Resistance to Anti-PD-1/PD-L1 Immunotherapy by Negatively Regulating Proinflammatory Chemokines and Anticancer Immunity(2023/01/15)

  作者：Zhiyong Cai, Jinbo Chen, Zhengzheng Yu

  期刊：Advanced Science

  DOI：10.1002/advs.202207155

  影响因子 ：15.100

  引用产品：CL-0227

• WD repeat protein 54-mediator of ErbB2-driven cell motility 1 axis promotes bladder cancer tumorigenesis and metastasis and impairs chemosensitivity(2023/01/07)

  作者：Xiaosong Wei, Beibei Wang, Zixin Wu

  期刊：CANCER LETTERS

  DOI：10.1016/j.canlet.2023.216058

  影响因子 ：9.700

  引用产品：CL-0002 CL-0125 CL-0222 CL-0227 CL-0463 CL-0628 PM150410 PM150710 PM150910 PM151010

• Deciphering the immunological and prognostic features of bladder cancer through platinum-resistance-related genes analysis and identifying potential therapeutic target P4HB(2023/09/18)

  作者：Situ Xiong, Sheng Li, Jin Zeng

  期刊：Frontiers in Immunology

  DOI：10.3389/fimmu.2023.1253586

  影响因子 ：7.300

  引用产品：CL-0227

• A novel CD8+ T cell-related gene signature for predicting the prognosis and immunotherapy efficacy in bladder cancer(2023/08/14)

  作者：Fei Lin, Zhibin Ke, Yuting Xue

  期刊：INFLAMMATION RESEARCH

  DOI：10.1007/s00011-023-01772-6

  影响因子 ：6.700

  引用产品：CL-0002 CL-0227

• Ferredoxin 1 is a cuproptosis-key gene responsible for tumor immunity and drug sensitivity: A pan-cancer analysis.(2022/09/21)

  作者：Longfei Yang, Yuwei Zhang, Yang Wang

  期刊：Frontiers in Pharmacology

  DOI：10.3389/fphar.2022.938134

  影响因子 ：5.600

  引用产品：CL-0002 CL-0010 CL-0052 CL-0075 CL-0109 CL-0185 CL-0222 CL-0227 CM-H019 PM150110 PM150210 PM150910

• Lethal activity of BRD4 PROTAC degrader QCA570 against bladder cancer cells(2023/01/17)

  作者：Qiang Wang, Baohu Li, Wenkai Zhang

  期刊：Frontiers in Chemistry

  DOI：10.3389/fchem.2023.1121724

  影响因子 ：5.500

  引用产品：CL-0222 CL-0227 PB180120 PM150110 PM150410

• CUDC‑101 is a potential target inhibitor for the EGFR‑overexpression bladder cancer cells(2023/10/12)

  作者：Zhenxing Wang, Lanxin Li, Chunhong Chu

  期刊：INTERNATIONAL JOURNAL OF ONCOLOGY

  DOI：10.3892/ijo.2023.5579

  影响因子 ：5.200

  引用产品：CL-0227

• Unveiling clinical significance and tumor immune landscape of CXCL12 in bladder cancer: Insights from multiple omics analysis(2023/12/12)

  作者：Zhouting Tuo, Dechao Feng, Zhiwei Jiang

  期刊：Chinese Journal of Cancer Research

  DOI：10.21147/j.issn.1000-9604.2023.06.12

  影响因子 ：5.100

  引用产品：CL-0227

• CDK2 and CDK4 targeted liensinine inhibits the growth of bladder cancer T24 cells(2023/07/07)

  作者：Hanbing Jiang, Siying Zhu, Bin Wu

  期刊：CHEMICO-BIOLOGICAL INTERACTIONS

  DOI：10.1016/j.cbi.2023.110624

  影响因子 ：5.100

  引用产品：CL-0227

• CRTAC1 (Cartilage acidic protein 1) inhibits cell proliferation, migration, invasion and epithelial-mesenchymal transition (EMT) process in bladder cancer by downregulating Yin Yang 1 (YY1) to inactivate the TGF-β pathway(2021/11/24)

  作者：Jianghua Yang, Li Fan, Xiaoxing Liao

  期刊：Bioengineered

  DOI：10.1080/21655979.2021.1974645

  影响因子 ：4.900

  引用产品：CL-0002 CL-0222 CL-0227

• POLR3G promotes EMT via PI3K/AKT signaling pathway in bladder cancer(2023/11/07)

  作者：Hualin Chen, Lin Ma, Wenjie Yang

  期刊：FASEB JOURNAL

  DOI：10.1096/fj.202301095R

  影响因子 ：4.800

  引用产品：CL-0227

• The oncogenic role of TFAP2A in bladder urothelial carcinoma via a novel long noncoding RNA TPRG1-AS1/DNMT3A/CRTAC1 axis(2022/11/21)

  作者：Jiani He, Changming Dong, Hao Zhang, Yuanjun Jiang, Tao Liu, Xiaojun Man

  期刊：CELLULAR SIGNALLING

  DOI：10.1016/j.cellsig.2022.110527

  影响因子 ：4.800

  引用产品：CL-0002 CL-0005 CL-0125 CL-0222 CL-0227 CL-0431

• A pan-cancer analysis of DDR1 in prognostic signature and tumor immunity, drug resistance(2023/04/08)

  作者：Longfei Yang, Yuwei Zhang, Yifan Tang

  期刊：Scientific Reports

  DOI：10.1038/s41598-023-27975-9

  影响因子 ：4.600

  引用产品：CL-0002 CL-0010 CL-0052 CL-0075 CL-0109 CL-0185 CL-0222 CL-0227 CM-H019 PM150110 PM150210 PM150910

• CircRPPH1 accelerates the proliferation and migration of bladder cancer via enhancing the STAT3 signaling pathway(2023/03/31)

  作者：Xiao Liu, Yonghua Tong, Qiu Huang

  期刊：ONCOLOGY REPORTS

  DOI：10.3892/or.2023.8540

  影响因子 ：4.200

  引用产品：CL-0002 CL-0227

• Anti-tumor effect of AZD8055 against bladder cancer and bladder cancer-associated macrophages(2023/03/06)

  作者：Weimin Hu, Yunlong Zhang, Jinzhuo Ning

  期刊：Heliyon

  DOI：10.1016/j.heliyon.2023.e14272

  影响因子 ：4.000

  引用产品：CL-0002 CL-0203 CL-0227 CL-0233 CL-0463

• CENPW knockdown inhibits progression of bladder cancer through inducing cell cycle arrest and apoptosis(2024/01/01)

  作者：Peng Zhang, Qian Yang, Xulong Chen

  期刊：Journal of Cancer

  DOI：10.7150/jca.90449

  影响因子 ：3.900

  引用产品：CL-0227

• Rad54L promotes bladder cancer progression by regulating cell cycle and cell senescence(2022/09/07)

  作者：Yinzhao Wang, Tailai Zhou, Hengxing Chen

  期刊：MEDICAL ONCOLOGY

  DOI：10.1007/s12032-022-01751-7

  影响因子 ：3.400

  引用产品：CL-0002 CL-0203 CL-0227

• Long Noncoding RNA HAND2-AS1 Suppresses Cell Proliferation, Migration, and Invasion of Bladder Cancer via miR-17-5p/KLF9 Axis(2022/01/10)

  作者：Xiaoming Yang, Xiaosong Wei, Chengzhi Yi

  期刊：DNA and Cell Biology

  DOI：10.1089/dna.2021.0637

  影响因子 ：3.100

  引用产品：CL-0002 CL-0222 CL-0227 CL-0463 CL-0628

• Effects of targeted Notch1 silencing on the biological processes of the T24 and 5637 cells in vitro(2021/2/21)

  作者：Kewen Zheng, Xiaomin Han, Yan Su

  期刊：Oncology Letters

  DOI：10.3892/ol.2021.12566

  影响因子 ：2.900

  引用产品：CL-0227

• Hsa_circ_0008035 Knockdown Inhibits Bladder Cancer Progression through miR-1184/RAP2B Axis(2023/03/23)

  作者：Yang Fu, Kun Liu, Xi Jiang

  期刊：UROLOGIA INTERNATIONALIS

  DOI：10.1159/000527873

  影响因子 ：1.600

  引用产品：CL-0002 CL-0222 CL-0227

• Elevated 8-oxo-7,8-dihydro-2′-deoxyguanosine in genome of T24 bladder cancer cells induced by halobenzoquinones(2017/5/22)

  作者：Tian Xu, Junfa Yin, Shaokun Chen

  期刊：Journal Of Environmental Sciences-China

  DOI：10.1016/j.jes.2017.05.024

  影响因子 ：0.000

  引用产品：CL-0227

点击展开收起列表